Healthcare
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery (“SRS”) Annual Meeting to be held in Fort Lauderdale, FL, July 23-26, 2026.* MAIN CONGRESS SESSIONS Real-world Outcomes after MRI-guided Transurethral Ultrasound
About this update from Profound Medical Corp
TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery ("SRS") Annual Meeting to be held in Fort Lauderdale, FL, July 23-26, 2026.* MAIN CONGRESS SESSIONS Dr. Meng commented, "UT Southwestern has helped pioneer the TULSA Procedure for prostate cancer, having reached the 100 th procedure milestone back in 2022 , well before the CPT Category 1 codes became effective in January 2025. I am honored by this opportunity to share my experience, both as a surgeon and a researcher, at SRS2026."
View stock analysis, news, and events for Profound Medical Corp